Norbert W. Bischofberger, EVP, R&D and CSO at GILEAD SCIENCES INC (GILD), sold 70,000 shares at $97.81 ($6.9M) on 2015-01-15, disclosed to the SEC on 2015-01-20.
Scheduled sale ($6.9M) by EVP, R&D and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $97.81 | 32,142 | $3.1M | 45.6% |
| 2 | $98.77 | 26,179 | $2.6M | 37.5% |
| 3 | $99.62 | 11,679 | $1.2M | 16.9% |
| Total | $98.47 avg | 70,000 | $6.9M | 100% |
| Filing → |
| KRON | BUY | 2023-11-17 | $2.7M | — | Filing → |
| KRON | BUY | 2022-05-19 | $3.4M | — | Filing → |
| KRON | BUY | 2021-12-08 | $347K | — | Filing → |